Pharmacokinetic, pharmacodynamic and pharmacogenetic study of nab-paclitaxel (nanoparticle albumin bound-paclitaxel) in patients with advanced solid tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Pharmacogenomic; Pharmacokinetics
- 08 Oct 2015 Biomarkers information updated
- 25 Sep 2008 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 08 Aug 2007 New trial record.